Medical Marijuana: Nurses’s Knowledge Can Improve Patient Care
Medical cannabis use is legal in more than half of the United States. Nurses who are well educated on the topic can improve patient care.
Related Articles
BCMA/CD19–Targeting CAR T-Cell Therapy Safely Produces Favorable Outcomes in Newly Diagnosed Multiple Myeloma
GC012F, a BCMA/CD19–targeted CAR T-cell therapy, safely produced favorable outcomes in patients with newly diagnosed multiple myeloma after induction therapy.
Two Phase 3 Trials of Pembrolizumab in NSCLC, CSCC to Be Discontinued By Merck
Merck has discontinued the KEYNOTE-867 and KEYNOTE-630 trials evaluating pembrolizumab in non-small cell lung cancer and cutaneous squamous cell carcinoma.
Companion Diagnostics for Olaparib Plus Abiraterone Acetate Gains FDA Approval in BRCA+ mCRPC
Companion diagnostics have been approved by the FDA for olaparib plus abiraterone in patients with metastatic castration-resistant prostate cancer.
Longer Duration of Adjuvant Trastuzumab May Further Improve DFS Rates in ERBB2-Positive Breast Cancer
Adjuvant trastuzumab reveals associations with improved disease-free survival in 1-year vs 9-week administration of the drug in patients with ERBB2-positive breast cancer.
Bortezomib Injectable Receives FDA Approval for Multiple Myeloma and MCL
The FDA approved Boruzu, a new presentation of bortezomib, for subcutaneous or intravenous administration in patients with multiple myeloma and mantle cell lymphoma.
Active Surveillance May Benefit Certain Patients With Small Nonfunctional Pancreatic NETs
This retrospective review demonstrates the increased use of active surveillance in patients with small nonfunctional pancreatic neuroendocrine tumors.
Tisagenlecleucel Moves to Earlier Lines of Therapy for Pediatric, Young Adults With Relapsed/Refractory B-ALL
Pediatric and young adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia are receiving tisagenlecleucel in earlier lines of therapy.
Oral Cannabis Extract May Be Beneficial as Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting
Oral cannabis extract may be useful as an adjunct for chemotherapy-induced nausea and vomiting, although it may be associated with additional adverse events.
A First-Time Comparison Reveals the Efficacy of Abiraterone Acetate Compared With Enzalutamide in Prostate Cancer
Enzalutamide produces strong indication of improvements in OS, PCS, TTS, and TTR compared with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC).
Understanding the Mechanism of Action Behind PARP Inhibitors for Prostate Cancer
Michael Lai, ARNP, explained the mechanism of action of PARP inhibitors for the treatment of patients with prostate cancer.